Figure 7.

Relative goodness of fit of regression models evaluating the association between the prevalence of 7-valent pneumococcal conjugate vaccine serotypes among healthy children in different age ranges and invasive pneumococcal disease in adults, Israel, 2009–2016. A) Adults aged 18–39 years; B) adults aged 40–64 years; C) adults aged ≥65 years. The goodness-of-fit (model likelihood) values were averaged across all of the models in which the population direct effect included the indicated pediatric age.